肝硬化发生自发性细菌性腹膜炎的危险因素分析

doi:10.3969/j.issn.1672-5069.2011.05.012

Abstract

Abstract: Objective To explore the risk factors of spontaneous bacterial peritonitis in patients with liver cirrhosis. Methods 398 patients with liver cirrhosis were divided into spontaneous bacterial peritonitis group（n=135）and non-spontaneous bacterial peritonitis group（n=263）. The predisposing factors in the two groups were compared. Results There were significant differences in history of SBP，ascites period，diabetes mellitus，total protein in ascitic fluid，digestive tract hemorrhage，Child-Pugh grades，antibiotic prophylaxis，blood Na+，serum TBil，ALB and PT between the two groups（P<0.01）. Conclusions The incidences of SBP is related to some factors，which might be properly managed in order to reduce the occurrence of spontaneous bacterial peritonitis in patients with liver cirrhosis.

Key words: Liver cirrhosis, Spontaneous bacterial peritonitis, Risk factors

ZHAN Guoqing，TAN Huabing，LI Fang，et al.. Risk factors of spontaneous bacterial peritonitis in patients with liver cirrhosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2011, 14(5): 349-350.

References

[1] STRAUSS E，CALY WR. Spontaneous bacterial peritonitis：a therapeutic update[J]. Expert Rev Anti-Infect Ther，2006，4（2）:249-260.
[2] 中华医学会传染病与寄生虫病学分会和肝病学分会.病毒性肝炎防治方案[J]. 中华肝脏病杂志，2000，8（6）:324-329.
[3] MOORE KP，WONG F，GINES P，et al. The management of ascites in cirrhosis:report on the consensus conference of the International Ascites Club[J]. Hepatology，2003，38 （3）:258-266.
[4] GARCLA-TSAO G. Current management of the placations of cirrhosis and portal hypertension：variceal hemorrhage，ascites，and spontaneous bacterial peritonitis[J]. Gastroenterology，2001，120（3）:726-748.
[5] RIMOLA A. Diagnosis，treatment and prophylaxis of spontaneous bacterial peritonitis:a consensus document[J]. Hepatology，2000，32（1）:142-153.
[6] 李建阳，吕晓菲，刘福文，等. 自发性细菌性腹膜炎54例临床分析[J]. 实用肝脏病杂志，2008，11（1）:46-47.
[7] RIMOLA A，GARCIA-TSAO G，NAVASA M，et al. Diagnosis， treatment and prophylaxis of spontaneous bacterial peritonitis:a consensus document International Ascites Club[J]. J Hepatol，2000，32（1）:142-153.
[8] 李易，韩盛玺，齐建康. 肝硬化自发性细菌性腹膜炎的影响因素分析[J]. 西部医学，2009，2l（4）:590-593.
[9] 占国清，谭华炳，朱琳，等. 145例肝硬化失代偿期低钠血症的回顾性分析[J]. 临床肝胆病杂志，2010，26（2）:194-195，198.
[10] 李井华，罗忠金. 肝硬化失代偿期并发低钠血症的原因及治疗现状[J]. 实用临床医学，2008，9（9）:136.
[11] 任明，王滔明，刘思纯，等. 肝硬化腹水并发自发性腹膜炎危险因素的探讨[J]. 中华内科杂志，2001，40（1）:41-42.

[1]	Chen Shuai, Yang Changqing.. Pathogenesis and risk factors of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 761-764.
[2]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[3]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[4]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[5]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[6]	Wang Yueyuan, Wang Yan, Zhang Dandan. Short-term efficacy of terlipressin and octreotide combination in treatment of cirrhotic patients complicated by hepatorenal syndrome [J]. Journal of Practical Hepatology, 2019, 22(5): 684-687.
[7]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[8]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.
[9]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[10]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[11]	Chen Shan, Zhuang Huashuai, Xing Yixi, et al. Preventive application of meropenem in patients with liver cirrhosis complicated by upper gastrointestinal bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 704-707.
[12]	Xu Qilin, Hao Shaohuan, Ran Bo. Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis and portal hypertension [J]. Journal of Practical Hepatology, 2019, 22(5): 708-711.
[13]	Jin Lianghong, Li Xingjie, Guan Hongbo, et al. Clinical value of dual-energy CT iodine quantification combined with dynamic contrast-enhanced MRI in evaluating hepatic hemodynamics and liver functions in patients with hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 712-715.
[14]	Bian Xinqu, Chen Jie, Liu Yanmin, et al. Serum thyroid hormone level changes in patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy [J]. Journal of Practical Hepatology, 2019, 22(5): 716-719.
[15]	Qiu Jun, Wang Xueqing, Zhang Bo, et al. Percutaneous choledocholithotomy for the treatment of patients with intrahepatic bile duct stones [J]. Journal of Practical Hepatology, 2019, 22(5): 744-747.

Risk factors of spontaneous bacterial peritonitis in patients with liver cirrhosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments